WHO Kick-Starts Pilot For Prequalification Of Biologics/Biosimilars
Manufacturers are being invited to submit expressions of interest in relation to two anticancer monoclonal antibodies on the WHO's essential list of medicines.
You may also be interested in...
Celltrion's Truxima has become the first rituximab biosimilar, and just the second biosimilar overall, to be prequalified by the World Health Organization.
Samsung Bioepis’ Ontruzant trastuzumab biosimilar has become the first biosimilar to be prequalified by the World Health Organization.
The World Health Organization has taken an “important first step” towards increased collaboration with the generics and biosimilars industries through an agreement with the International Generic and Biosimilar Medicines Association to promote access to medicines.